BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 3122646)

  • 1. Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease.
    Kowall NW; Kosik KS
    Ann Neurol; 1987 Nov; 22(5):639-43. PubMed ID: 3122646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
    Papasozomenos SC
    Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.
    Kowall NW; Beal MF
    Ann Neurol; 1988 Feb; 23(2):105-14. PubMed ID: 2897822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alzheimer's disease: study of the distribution of tau proteins constituting helical filament pairs in human central nervous tissue].
    Parent M; Delacourte A; Défossez A; Hémon B; Han KK; Petit H
    C R Acad Sci III; 1988; 306(13):391-7. PubMed ID: 3136867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtubular reorganization and dendritic growth response in Alzheimer's disease.
    McKee AC; Kowall NW; Kosik KS
    Ann Neurol; 1989 Nov; 26(5):652-9. PubMed ID: 2817839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues.
    Shin RW; Iwaki T; Kitamoto T; Tateishi J
    Lab Invest; 1991 May; 64(5):693-702. PubMed ID: 1903170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
    Joachim CL; Morris JH; Kosik KS; Selkoe DJ
    Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of axonal paired helical filament-tau in Alzheimer's disease: submicroscopic localization.
    Bondareff W; Harrington CR; McDaniel SW; Wischik CM; Roth M
    J Neurosci Res; 1994 Aug; 38(6):664-9. PubMed ID: 7807582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
    Papasozomenos SC
    Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
    Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
    Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease.
    Shin RW; Ogomori K; Kitamoto T; Tateishi J
    Am J Pathol; 1989 Jun; 134(6):1365-71. PubMed ID: 2502927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neurites and neuropil threads.
    Schmidt ML; Lee VM; Trojanowski JQ
    Lab Invest; 1991 Mar; 64(3):352-7. PubMed ID: 1706004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition.
    Tabaton M; Mandybur TI; Perry G; Onorato M; Autilio-Gambetti L; Gambetti P
    Ann Neurol; 1989 Dec; 26(6):771-8. PubMed ID: 2557796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.
    Goedert M
    Arzneimittelforschung; 1995 Mar; 45(3A):403-9. PubMed ID: 7763334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease.
    Thal DR; Härtig W; Schober R
    J Hirnforsch; 1998; 39(2):175-81. PubMed ID: 10022341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of neuronal thread protein expression in Alzheimer's disease.
    De La Monte SM; Carlson RI; Brown NV; Wands JR
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1038-50. PubMed ID: 8858001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.